Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Tilray® Signs Letter of Intent with Pharmasave

Tilray
Posted on: 22 Mar 18

Tilray Canada Ltd. (Tilray) announced today that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada.

Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists. Tilray is a global pioneer in medical cannabis research, cultivation, processing and distribution, and was the first medical cannabis company with a North American production facility to obtain GMP certification in accordance with the European Medicines Agency’s (EMA) standards. Tilray currently supplies tens of thousands of patients with high-quality, GMP-certified products in ten countries spanning five continents.

Pharmasave is a member-governed cooperative of more than 650 independently owned community pharmacies across Canada. Pharmasave believes that pharmacists play an important role in helping to improve patient care. For more than a year, Pharmasave has been providing Pharmasave Pharmacists, as medication management experts, with education and resources on medical cannabis, to help them better understand the current regulations and learn more about the possible uses, benefits and risks of medical cannabis. For those patients who take multiple medications and may have a complex medication therapy, pharmacists can work with patients and physicians to safely achieve positive health outcomes.

“Tilray’s products are available in ten countries around the world. Our products can be purchased by patients in pharmacies in each of those countries except Canada. Today’s announcement puts us in a strong position to expand the availability of our products to additional patients in need throughout Canada,” said Brendan Kennedy, Tilray CEO. “It’s exciting that we have the potential to bring our medical cannabis products to patients via pharmacies in Canada with a partner like Pharmasave, a company that shares our commitment to patient safety and access.”

About Tilray

Tilray is a global pioneer in cannabis research, cultivation, processing and distribution currently serving tens of thousands of patients in ten countries spanning five continents.

About Pharmasave Drugs National

With more than 650 stores across the country, Pharmasave is one of Canada's leading independent pharmacy and drugstore retailers. Since being founded in 1981, Pharmasave has focused on building a national platform of community-based retail outlets designed to provide customers with exceptional service, products and advice. Each Pharmasave store operates to serve its individual community, which ensures both programs and services tailored to the needs of local customers and a commitment to helping all customers Live Well With Pharmasave.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180322005127/en/

Business Wire
www.businesswire.com

Last updated on: 22/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.